YD Bio Limited (YDESW)Taipei, Taiwan | NasdaqGM
0.50 USD
+0.04
(8.152%)
⇧
(April 17, 2026, 4 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:19 p.m. EDT
Reject; catastrophic fundamentals with deep operating losses, massive negative free cash flow, and zero dividend history make this a high-risk speculative play with no margin of safety. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 0.338 |
| Revenue per Share | 0.466 |
| Beta | 0.22 |
| Profit Margins | -276.58% |
| Previous Name | Breeze Holdings Acquisition Corp. |
| Website | https://www.ydesgroup.com |
| Attribute | Value |
|---|---|
| Address1 | No. 3, Xingnan St. |
| Address2 | 12F. Nangang Dist. |
| Ask | 0.6193 |
| Ask Size | 22 |
| Beta | 0.221 |
| Bid | 1.56 |
| Bid Size | 1 |
| Book Value | 4.571 |
| City | Taipei |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4975 |
| Current Ratio | 13.183 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.55 |
| Day Low | 0.4531 |
| Debt To Equity | 0.338 |
| Display Name | YD Bio |
| Ebitda | -1,357,195 |
| Ebitda Margins | -2.6592898 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.55 |
| Fifty Two Week High Change | -0.05250001 |
| Fifty Two Week High Change Percent | -0.09545456 |
| Fifty Two Week Low | 0.4531 |
| Fifty Two Week Low Change | 0.044400007 |
| Fifty Two Week Low Change Percent | 0.09799163 |
| Fifty Two Week Range | 0.4531 - 0.55 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 321,096 |
| Free Cashflow | -3,875,569 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.3044 |
| Gross Profits | 155,356 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,025-08-29 |
| Language | en-US |
| Long Business Summary | YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. |
| Long Name | YD Bio Limited |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1898493574 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -1,411,559 |
| Open | 0.5 |
| Operating Cashflow | -1,836,818 |
| Operating Margins | -4.44588 |
| Prev Name | Breeze Holdings Acquisition Corp. |
| Previous Close | 0.46 |
| Price Hint | 4 |
| Price To Book | 0.10883833 |
| Profit Margins | -2.76581 |
| Quick Ratio | 12.906 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.037499994 |
| Regular Market Change Percent | 8.152173 |
| Regular Market Day High | 0.55 |
| Regular Market Day Low | 0.4531 |
| Regular Market Day Range | 0.4531 - 0.55 |
| Regular Market Open | 0.5 |
| Regular Market Previous Close | 0.46 |
| Regular Market Price | 0.4975 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 19,391 |
| Return On Assets | -0.25432 |
| Return On Equity | -0.42689 |
| Revenue Growth | 0.956 |
| Revenue Per Share | 0.466 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | YD Bio Limited Warrants |
| Source Interval | 15 |
| Symbol | YDESW |
| Total Cash | 3,132,298 |
| Total Cash Per Share | 2.173 |
| Total Debt | 22,265 |
| Total Revenue | 510,360 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 19,391 |
| Website | https://www.ydesgroup.com |
| Zip | 115,001 |